Walking Fish Therapeutics

WFT-2 RD solid tumors; WFT-3 RD rare disease/regenerative medicine

Walking Fish Therapeutics focuses on regenerative medicine and oncology solutions, inspired by the regenerative capabilities of the Axolotl. Their scientific focus revolves around developing B-cell based protein therapies to treat serious diseases, such as cancers and autoimmune conditions. Their engineered B-cells are used as potent protein and antibody factories with the potential for infectious, deficiency, and autoimmune diseases. Engineered B cells especially have great potential for cancer by improving the antitumor immune response. These B cells and CAR B cells can target specific tissues for a selective, local response. This advanced technology along with the team’s expertise in protein therapeutics and immuno-oncology holds promise for those with serious diseases and unmet medical needs.

Jobs: